Theralase Technologies Inc. (TSXV: TLT)
Canada
· Delayed Price · Currency is CAD 0.250
-0.020 (-7.41%)
Dec 20, 2024, 3:59 PM EST
Theralase Technologies Income Statement
Financials in millions CAD. Fiscal year is January - December.
Millions CAD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Revenue | 0.99 | 1.07 | 1.14 | 0.78 | 0.93 | 0.96 | Upgrade
|
| Revenue Growth (YoY) | -4.42% | -6.00% | 45.85% | -15.98% | -3.62% | -44.41% | Upgrade
|
| Cost of Revenue | 0.48 | 0.51 | 0.51 | 0.47 | 0.69 | 0.63 | Upgrade
|
| Gross Profit | 0.51 | 0.56 | 0.63 | 0.31 | 0.24 | 0.34 | Upgrade
|
| Selling, General & Admin | 2.08 | 2.17 | 1.58 | 1.93 | 2.52 | 3.32 | Upgrade
|
| Research & Development | 2.8 | 2.98 | 4.28 | 2.92 | 3.45 | 4.16 | Upgrade
|
| Operating Expenses | 4.87 | 5.16 | 5.86 | 4.85 | 5.97 | 7.48 | Upgrade
|
| Operating Income | -4.36 | -4.59 | -5.23 | -4.54 | -5.72 | -7.14 | Upgrade
|
| Interest Expense | -0.03 | -0.03 | -0.02 | -0.01 | -0.01 | -0.01 | Upgrade
|
| Interest & Investment Income | 0.06 | 0.05 | 0.03 | 0.02 | 0.1 | 0.03 | Upgrade
|
| Currency Exchange Gain (Loss) | -0 | 0 | -0.03 | -0.02 | 0 | -0.02 | Upgrade
|
| EBT Excluding Unusual Items | -4.33 | -4.57 | -5.25 | -4.54 | -5.62 | -7.14 | Upgrade
|
| Asset Writedown | - | - | - | - | - | -0.28 | Upgrade
|
| Legal Settlements | - | - | 0.01 | 0.13 | - | - | Upgrade
|
| Other Unusual Items | - | - | - | - | 0.03 | - | Upgrade
|
| Pretax Income | -4.33 | -4.57 | -5.24 | -4.41 | -5.6 | -7.41 | Upgrade
|
| Net Income | -4.33 | -4.57 | -5.24 | -4.41 | -5.6 | -7.41 | Upgrade
|
| Net Income to Common | -4.33 | -4.57 | -5.24 | -4.41 | -5.6 | -7.41 | Upgrade
|
| Shares Outstanding (Basic) | 233 | 220 | 208 | 204 | 204 | 145 | Upgrade
|
| Shares Outstanding (Diluted) | 233 | 220 | 208 | 204 | 204 | 145 | Upgrade
|
| Shares Change (YoY) | 7.23% | 5.79% | 1.79% | - | 41.19% | 10.88% | Upgrade
|
| EPS (Basic) | -0.02 | -0.02 | -0.03 | -0.02 | -0.03 | -0.05 | Upgrade
|
| EPS (Diluted) | -0.02 | -0.02 | -0.03 | -0.02 | -0.03 | -0.05 | Upgrade
|
| Free Cash Flow | -4.14 | -4.11 | -5.17 | -4.13 | -4.61 | -7.1 | Upgrade
|
| Free Cash Flow Per Share | -0.02 | -0.02 | -0.02 | -0.02 | -0.02 | -0.05 | Upgrade
|
| Gross Margin | 51.71% | 52.52% | 55.17% | 39.70% | 26.24% | 35.13% | Upgrade
|
| Operating Margin | -442.29% | -429.25% | -459.48% | -581.77% | -615.91% | -740.86% | Upgrade
|
| Profit Margin | -438.78% | -427.06% | -459.81% | -565.06% | -602.56% | -769.04% | Upgrade
|
| Free Cash Flow Margin | -419.63% | -384.01% | -454.37% | -529.21% | -496.25% | -736.44% | Upgrade
|
| EBITDA | -4.18 | -4.4 | -4.99 | -4.32 | -5.5 | -6.94 | Upgrade
|
| D&A For EBITDA | 0.18 | 0.19 | 0.24 | 0.22 | 0.22 | 0.2 | Upgrade
|
| EBIT | -4.36 | -4.59 | -5.23 | -4.54 | -5.72 | -7.14 | Upgrade
|
| Advertising Expenses | - | 0.02 | 0.02 | 0.05 | 0.08 | 0.16 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.